Hello, Fool! | Login | Signup | My Fool
Oct 16, 2008 12:45 AM ET | Feedback | Site Changes | Help
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
View All Commentary (EXEL)
Recs
predfern (< 20) Submitted: 2/01/07 12:03 AM : Start Price: $9.80 EXEL Score: -20.10
Eleven drug candidates that are either in clinical testing or about to begin it. This magnitude of clinical development is unmatched for a biotech the size of Exelixis. Partnerships with many of the leading pharmaceutical and biotech companies.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK